Camilla Binks
Family · Scottsdale, AZNPI 1982096418
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (50.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Nalu Medical, Inc. at 58.2% of the total. Reporting peaked in 2022 at $33,456 and has fallen 95.0% since, to $1,661 in 2025. Among family clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 437 payments — averaging $140.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$36K
- Nevro Corp.$10K
- Saluda Medical Americas, Inc.$6K
- Boston Scientific$3K
- Abbott$2K
- Vertos Medical, Inc.$1K
- plus $3K from 25 others
What the payments were for
- Consulting fees$31,33851%
- Speaking & faculty fees$4,3397%
- Travel & lodging$11,65219%
- Food & beverage$14,22723%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 96 | $35,827 |
| Nevro Corp. | 74 | $10,473 |
| Saluda Medical Americas, Inc. | 66 | $5,746 |
| Boston Scientific | 37 | $2,843 |
| Abbott | 39 | $2,470 |
| Vertos Medical, Inc. | 15 | $1,228 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $410 |
| Medtronic | 9 | $397 |
| Relievant Medsystems, Inc. | 3 | $371 |
| Biotronik NRO, Inc. | 5 | $315 |
| Collegium Pharmaceutical, Inc. | 17 | $281 |
| Globus Medical(2 entities) | 4 | $263 |
| Axonics, Inc. | 4 | $157 |
| Biohaven Pharmaceuticals, Inc. | 3 | $153 |
| Biodelivery Sciences International, Inc. | 8 | $121 |
| AbbVie | 5 | $107 |
| Almatica Pharma LLC | 4 | $70 |
| Foundation Fusion Solutions, LLC | 5 | $52 |
| GRT US Holding, Inc. | 1 | $34 |
| Scilex Pharmaceuticals Inc. | 2 | $33 |
| Avanos Medical | 1 | $31 |
| Averitas Pharma Inc. | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| ZOLL Respicardia, Inc. | 1 | $20 |
| Redhill Biopharma Inc. | 1 | $20 |
| Valinor Pharma, LLC | 1 | $19 |
| Impactortho, Inc. | 1 | $18 |
| Otto Bock Healthcare LP | 1 | $17 |
| Amgen | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Protega Pharmaceutials Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$34,369
- Omnia$6,831
- Evoke$4,244
- Senza$2,171
- SUPERION$1,800
- Intracept$995
- PROCLAIM$936
- mild Device Kit$897
- Axium$569
- Superion Indirect Decompression System$375
- Prospera$239
- Evoke SCS$177
- ETERNA$171
- Proclaim IPG$167
- INTELLIS$159
- INCEPTIV$139
- NURTEC ODT$124
- XLIF$122
How this compares
$61,567 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 25 | $12,908 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 263 | $8,509 |
| ButransBuprenorphine | 11 | $5,798 |
| Gabapentin | 322 | $5,245 |
| MovantikNaloxegol Oxalate | 13 | $5,183 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 213 | $4,550 |
| OxycontinOxycodone Hcl | 13 | $4,348 |
| Oxycodone Hcl | 237 | $3,914 |
| Buprenorphine | 14 | $3,789 |
| Celecoxib | 133 | $2,258 |
| Lidocaine | 12 | $1,727 |
| Pregabalin | 98 | $1,549 |
| Methocarbamol | 95 | $1,462 |
| Cyclobenzaprine Hcl | 90 | $1,353 |
| Tramadol Hcl | 149 | $1,135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $281 | $12,90825 claims |
| Redhill Biopharma Inc.Movantik | $20 | $5,18313 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,119 family providers in Arizona.
Other family in Scottsdale
- Kaitlyn LouchheimScottsdale$208K
- Jennifer PrinceScottsdale$76K
- Jessica TapiaScottsdale$36K
- Dawn MougelScottsdale$34K
- Keegan RussellScottsdale$28K
- Jamie HowardScottsdale$14K
- Anna CramerScottsdale$14K
- Sharon MagalonaMesa$441K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.